Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.

doi:10.4274/tjh.2015.0041

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.

Turkish journal of haematology : official journal of Turkish Society of Haematology - 5 Sept 2016

Andıç Neslihan, Ünübol Mustafa, Yağcı Eren, Akay Olga Meltem, Yavaşoğlu İrfan, Kadıköylü Vefki Gürhan, Bolaman Ali Zahit

Abstract excerpt

OBJECTIVE: Myeloproliferative neoplasms (MPNs) share common clonal stem cells but show significant differences in their clinical courses. The aim of this retrospective study was to evaluate thrombotic and hemorrhagic complications, JAK2 status, gastrointestinal and cardiac changes, treatment modalities, and survival in MPNs in Turkish patients. MATERIALS AND METHODS: Medical files of 294 patients [112 essential...

Topics

Adolescent
Adult
Aged
Aged, 80 and over
Chronic Disease
Female
Hemorrhage
Humans
Hydroxyurea
Janus Kinase 2
Male

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Middle Aged

Mutation

Myeloproliferative Disorders

Quinazolines

Retrospective Studies

Risk Factors

Turkey

Source

Open in PubMed Open full text

Identifiers

PMID: 27094255
DOI: 10.4274/tjh.2015.0041
PMCID: PMC5111463

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.PMID 27094255Read ↗

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms.Semantic proximity Read ↗

Myeloproliferative Neoplasms: A Contemporary Review.Semantic proximity Read ↗

Myeloproliferative and lymphoproliferative disorders: State of the art.Semantic proximity Read ↗

[Myeloproliferative neoplasms: pathophysiology and therapeutic strategy].Semantic proximity Read ↗

The 2008 World Health Organization classification system for myeloproliferative neoplasmsSemantic proximity Read ↗

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.Semantic proximity Read ↗

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Current approaches to challenging scenarios in myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger.Semantic proximity Read ↗

[CURRENT CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS - WHAT IS IMPORTANT TO KNOW?]Semantic proximity Read ↗

Guidelines for the management of myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.